CYCLOPHOSPHAMIDE (NSC-26271)-1 IN UNCOMMON MALIGNANT NEOPLASMS IN CHILDREN.
D000293:Adolescent; D000505:Alopecia; D001254:Astrocytoma; D035843:Biomedical Research; D002294:Carcinoma, Squamous Cell; D002648:Child; D003520:Cyclophosphamide; D040181:Genetic Diseases, X-Linked; D006801:Humans; D007223:Infant; D007943:Leukemia, Hairy Cell; D007970:Leukopenia; D008168:Lung; D008206:Lymphatic Diseases; D008297:Male; D009325:Nausea; D009369:Neoplasms / Q000532:radiotherapy*; D016511:Severe Combined Immunodeficiency; D013724:Teratoma; D013736:Testicular Neoplasms; D013921:Thrombocytopenia; D014116:Toxicology; D014839:Vomiting
D003520:Cyclophosphamide
ADOLESCENCE; ALOPECIA; ASTROCYTOMA; CARCINOMA, EPIDERMOID; CHILD; CLINICAL RESEARCH; CYCLOPHOSPHAMIDE; INFANT; LEUKOPENIA; LUNG; NAUSEA; NEOPLASM RADIOTHERAPY; RETICULOENDOTHELIOSIS; TERATOID TUMOR; TESTICULAR NEOPLASMS; THROMBOPENIA; TOXICOLOGIC REPORT; VOMITING